logo
ASC issues public interest order against Charles DeBono in response to criminal conviction

ASC issues public interest order against Charles DeBono in response to criminal conviction

CALGARY, AB, Feb. 14, 2025 /CNW/ - The Alberta Securities Commission (ASC) has permanently banned Ontario resident Charles DeBono from participating in Alberta's capital market after a criminal court found that he was operating a Ponzi scheme.
In June 2022, DeBono was sentenced by the Ontario Superior Court of Justice to seven years in jail and ordered to pay restitution of more than $26 million after pleading guilty to one count of fraud over $5,000 and one count of laundering the proceeds of crime under the Criminal Code.
Between January 2013 and August 2017, DeBono sought investments in Debit Direct, a company he owned that purportedly provided point of sale debit machines to merchants. Investors were told that they were purchasing debit terminals for small businesses across Canada and that they would receive a portion from each transaction. DeBono raised up to $48 million from more than 500 investors, including over 100 Albertans. The Court found that Debit Direct was not a legitimate business and that DeBono was operating a Ponzi scheme; any returns investors received were paid from other investors' funds.
When considering the matter under the Securities Act (Alberta), an ASC panel found that it was in the public interest to issue an order. In its reasons, the panel stated that 'DeBono's misconduct – fraud – was extremely serious, involving hundreds of investors, a large amount of money, deceit, misrepresentation, and misappropriation of millions of dollars for his personal benefit.' The panel noted a 'significant need for strong sanctions to deter DeBono and others from similar misconduct in the future, and to protect Alberta investors and the Alberta capital market from further harm.'
On February 12, 2025, the panel ordered that DeBono:
must permanently cease trading in or purchasing any securities or derivatives, and that all exemptions contained in Alberta securities laws do not apply to him;
must immediately resign all positions he holds, and is permanently prohibited from becoming or acting, as a director or officer of any issuer, registrant, investment fund manager, recognized exchange, recognized self-regulatory organization, recognized clearing agency, recognized trade repository, designated rating organization or designated benchmark administrator; and
is permanently prohibited from engaging in investor relations activities, advising in securities or derivatives, becoming or acting as a registrant, investment fund manager or promoter, and acting in a management or consultative capacity in connection with activities in the securities market.
The ASC is the regulatory agency responsible for administering the province's securities laws. It is entrusted with fostering a fair and efficient capital market in Alberta and with protecting investors. As a member of the Canadian Securities Administrators, the ASC works to improve, coordinate and harmonize the regulation of Canada's capital markets.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter
Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter

Yahoo

timean hour ago

  • Yahoo

Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter

NASDAQ | TSX: ACB Achieves Record Annual Global Medical Cannabis Net Revenue1 of $244.4 million, representing 39% YoY growth Delivers Record Adjusted EBITDA1 of $49.7 million, representing 261% YoY growth Generates Annual Positive Free Cash Flow1 of $9.9 million Sustains Strong Balance Sheet with ~$185.3 million of Cash and Debt-Free Cannabis Business2 EDMONTON, AB, June 18, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the fourth quarter and fiscal year 2025 periods ending March 31, 2025. "We are pleased to report an exceptional year to our shareholders, highlighted by record annual global medical net revenue1, adjusted EBITDA1, and positive free cash flow1. These achievements underscore the thoughtful execution of our strategic plan, set us further apart from competitors, and strengthen our foundation for sustained and profitable growth," said Executive Chairman and Chief Executive Officer for Aurora, Miguel Martin. "Specific to Q4 2025, we ended our banner fiscal year by further strengthening our business model. International revenue more than doubled, representing 61% of global medical cannabis net revenue1. Plant propagation also increased significantly as we benefited from peak seasonality along with organic expansion. These top-line gains were complemented by a sharp year over year increase in adjusted EBITDA1 profitability and the third quarter of positive free cash flow1 generation." concluded Mr. Martin. _________________________________1 This press release includes certain non-GAAP financial measures, which are intended to supplement, not substitute for, comparable GAAP financial measures. See "Non-GAAP Measures" below for reconciliations of non-GAAP financial measures to GAAP financial measures. 2 Aurora's only remaining debt is non-recourse debt of $61.7 million relating to Bevo Farms Ltd as detailed in the March 31, 2025 Financial Statements. Fourth Quarter 2025 Highlights (Unless otherwise stated, comparisons are made between fiscal Q4 2025, Q3 2025, and Q4 2024 results and are in Canadian dollars) Consolidated Revenue and Adjusted Gross Profit:Total net revenue1 was $90.5 million, as compared to $67.4 million in the prior year period. The 34% increase from the prior year period was mainly due to 48% growth in our global medical cannabis business and 32% growth in our plant propagation business, slightly offset by lower quarterly revenue in our consumer cannabis business. Consolidated adjusted gross margin before fair value adjustments1 was 62% in Q4 2025 and 50% in the prior year period. Adjusted gross profit before FV adjustments1 was $54.2 million in Q4 2025 compared to $33.4 million in the prior year period, an increase of 62%. Medical Cannabis:Medical cannabis net revenue1 was $67.8 million, a 48% increase from the prior year period, delivering 75% of Aurora's Q4 2025 consolidated net revenue1 and 88% of adjusted gross profit before fair value adjustments1. The increase in medical cannabis net revenue1 of $22.1 million was primarily due to higher sales to Australia, Germany, Poland, and the UK, as well as increased revenue in Canada to insurance covered and self-paying patients. Adjusted gross margin before fair value adjustments1 on medical cannabis net revenue1 reached 70% for the three months ended March 31, 2025, compared to 66% in the prior year period. The adjusted gross margins before fair value adjustments1 improved through sustainable cost reductions, higher selling prices, and improved efficiency in production operations, including sourcing for Europe from Canada. Consumer Cannabis:Aurora's consumer cannabis net revenue1 was $8.2 million a 20% decrease compared to $10.2 million in the prior year period. The decrease was due to our continued decision to prioritize the supply of our GMP manufactured products to our high margin global medical cannabis business rather than the consumer business, which offers lower margins. Adjusted gross margin before fair value adjustments1 on consumer cannabis net revenue1 was 27%, an increase from 16% compared to the prior year period. The increase from the prior year period is primarily due to cost improvements resulting from spend efficiencies. Plant Propagation:Plant propagation net revenue1 was wholly comprised of the Bevo business, and contributed $13.8 million of net revenue1, a 32% increase compared to $10.4 million in the prior year period. The increase was a result of organic growth and expanded product offerings, both arising from increased capacity. Adjusted gross margin before fair value adjustments1 on plant propagation revenue was 37% for Q4 2025 and 25% for the prior year period. The fluctuations in the plant propagation adjusted gross margin before fair value adjustments1 is due to product mix with higher margin sales. Adjusted Selling, General and Administrative ("Adjusted SG&A"):Adjusted SG&A1 was $36.7 million in Q4 2025, which excludes $5.8 million of business transformation costs. The increase compared to the prior year period relates to higher freight and logistics costs, notably from sales to Europe with the increase in sourcing from Canada and incremental costs following the acquisition of MedReleaf Australia. Net Income (Loss):Net loss from continuing operations for the three months ended March 31, 2025 was $17.2 million compared to a net loss of $20.3 million for the prior year period. The decrease in net loss of $3.0 million compared to the three months ended March 31, 2024 is comprised of a decrease in gross profit of $18.8 million and an increase in operating expenses of $3.0 million, offset with other income in the current period $10.5 million compared to other expenses of $18.7 million during the three months ended March 31, 2024. Adjusted EBITDA:Adjusted EBITDA1 increased 619% to $16.7 million for the three months ended March 31, 2025 compared to $2.3 million for the prior year period. Fiscal Q1 2026 Expectations: Expect continued strong global cannabis revenue driven by improved performance in Canadian medical, comparable performance in consumer, offset by temporary declines in some of our international markets. Taken together, global cannabis should be slightly lower compared to Q4 2025 and is expected to improve in later quarters due to increased distribution and further innovation. Seasonally higher revenues for plant propagation as they complete their peak quarter, in line with historical seasonal trends. Margins to hold strong and we expect positive adjusted EBITDA1 to continue, with a decline versus Q4 FY25 due to lower revenue contributions from the higher margin international markets. Free cash flow1 is projected to remain positive, due to continued strong performance and improved operating cash use. Historical Quarterly Results:In connection with the audit of the annual consolidated financial statements as at and for the year ended March 31, 2025, the Company identified an error in inventory and cost of sales arising from intercompany profit eliminations, resulting in an overstatement of inventory and understatement of cost of sales. Additionally, the Company understated its lease liability during a period in which a rent concession was granted by the lessor. In respect of the Company's presentation of cash and cash equivalents and restricted cash, the Company determined that certain previously reported restricted cash held within its captives was accessible to the Company and therefore not restricted. The unrestricted portion has been reclassified to cash and cash equivalents. The Company has concluded that these errors are not material to any of the Company's previously-issued audited consolidated financial statements and unaudited condensed consolidated interim financial statements. Accordingly, the Company has concluded that an amendment to its previously-filed audited consolidated financial statements and unaudited condensed consolidated interim financial statements is not required. The revisions will be reflected in the comparative period of the Company's prospective condensed consolidated interim financial statements filings. There is no impact to the annual consolidated financial statements, however the comparative periods have been revised accordingly. The core balances impacted in the consolidated financial position and cash flow are: cash and cash equivalents, restricted cash, inventory and property, plant and equipment. In the consolidated statement of income (loss) the core areas impacted are: cost of sales, gross profit and net income (loss). A summary of the impact to its previously filed audited consolidated financial statements and unaudited condensed consolidated interim financial statements can be found in the historical quarterly results section of the FY25 Q4 MD&A, filed June 18, 2025 (the "MD&A"). Key Quarterly Financial Results ($ thousands, except Operational Results) Three months ended March 31, 2025 December 31, 2024(4) $ Change % Change March 31, 2024(3) $ Change % Change Financial ResultsNet revenue (1a) $90,538 $88,198 $2,340 3 % $67,411 $23,127 34 % Medical cannabis net revenue (1a) $67,776 $68,149 ($373) (1 %) $45,648 $22,128 48 % Consumer cannabis net revenue (1a) $8,166 $9,912 ($1,746) (18 %) $10,233 ($2,067) (20 %) Plant propagation revenue $13,770 $8,897 $4,873 55 % $10,416 $3,354 32 % Adjusted gross margin before FV adjustments on total net revenue (1b) 62 % 61 % N/A 1 % 50 % N/A 12 % Adjusted gross margin before FV adjustments on cannabis net revenue (1b) 65 % 63 % N/A 2 % 54 % N/A 11 % Adjusted gross margin before FV adjustments on medical cannabis net revenue (1b) 70 % 69 % N/A 1 % 66 % N/A 4 % Adjusted gross margin before FV adjustments on consumer cannabis net revenue (1b) 27 % 26 % N/A 1 % 16 % N/A 11 % Adjusted gross margin before FV adjustments on plant propagation net revenue (1b) 37 % 40 % N/A (3 %) 25 % N/A 12 % Adjusted SG&A expense(1d) $36,687 $31,263 $5,424 17 % $31,351 $5,336 17 % Adjusted EBITDA (1c) $16,678 $19,393 ($2,715) (14 %) $2,319 $14,359 619 % Free cash flow (1e) $2,495 $27,364 ($24,869) (91 %) ($21,866) $24,361 111 % Balance SheetWorking capital (1f) $367,465 $338,741 $28,724 8 % $301,985 $65,480 22 % Cannabis inventory and biological assets (2) $193,980 $212,075 ($18,095) (9 %) $148,112 $45,868 31 % Total assets $852,666 $862,297 ($9,631) (1 %) $838,673 $13,993 2 % (1) These terms are defined in the "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of this MD&A. Refer to the following sections for reconciliation of Non-GAAP Measures to the IFRS equivalent measure: a. Refer to the "Revenue" and "Cost of Sales and Gross Margin" section for a reconciliation of cannabis net revenue to the IFRS equivalent. b. Refer to the "Adjusted Gross Margin" section for reconciliation to the IFRS equivalent. c. Refer to the "Adjusted EBITDA" section for reconciliation to the IFRS equivalent. d. Refer to the "Operating Expenses" section for reconciliation to the IFRS equivalent. e. Refer to the "Liquidity and Capital Resources" section for a reconciliation to the IFRS equivalent. f. "Working capital" is defined as Current Assets less Current Liabilities as reported on the Company's Consolidated Statements of Financial Position. (2) Represents total biological assets and inventory, exclusive of merchandise, accessories, supplies, consumables and plant propagation biological assets. (3) Certain previously reported amounts have been adjusted to exclude the results of discontinued operations. (4) In connection with the audit of the annual consolidated financial statements as at and for the year ended March 31, 2025, the Company noted that inventory and lease obligation were misstated, impacting the condensed consolidat interim statements filed during the 2025 fiscal balances in the condensed consolidated interim financial statements as at and for the three months ended June 30, 2024, September 30, 2024 and December 31, 2024 were adjusted as a result and the amounts shown above reflect such adjustments. Refer to discussion under "Historical Quarterly Results" section of this MD&A for further detail. Conference Call Aurora will host a conference call today, Wednesday, June 18, 2025, to discuss these results. Miguel Martin, Chief Executive Officer, and Simona King, Chief Financial Officer, will host the call starting at 8:00 a.m. Eastern time | 6:00 a.m. Mountain Time. A question and answer session will follow management's presentation. DATE: Wednesday, June 18, 2025 TIME: 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time WEBCAST: Click Here About Aurora Cannabis Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at and follow us on X and LinkedIn. Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB". Forward Looking Statements This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding ethe Company's Q4 and full year FY2025 results, statements under the heading "Fiscal Q1 2026 Expectation", including, but not limited to those related to revenue growth and adjusted gross margins, revenue in the plant propagation segment, and expectations for positive adjusted EBITDA and positive free cash flow, statements regarding the Company's continued commitment to strategic growth, operational excellence, and long-term sustained profitability, as well as statements regarding the Company's conference call to discuss results. These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the magnitude and duration of potential new or increased tariffs imposed on goods imported from Canada into the United States, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations (with respect to the Transaction and more generally with respect to future acquisitions), management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information from dated June 17, 2025 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at and filed with and available on the U.S Securities and Exchange Commision's EDGAR ("SEC")\ website at The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law. The Company's annual consolidated financial statements, the MD&A and AIF are available as part of the Company's Annual Report on Form 40-F filed with the SEC and available under the Company's profile on the SEC's website. These documents are also available on the Company's website, and shareholders may receive hard copies of such documents free of charge upon request. Non-GAAP Measures This news release contains reference to certain financial performance measures that are not recognized or defined under IFRS (termed "Non-GAAP Measures"). As a result, this data may not be comparable to data presented by other licensed producers of cannabis and cannabis companies. Non-GAAP Measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company's operating results, underlying performance and prospects in a manner similar to Aurora's management. Accordingly, these non-GAAP Measures are intended to provide additional information and to assist management and investors in assessing financial performance and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. The information included under the heading "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" in the MD&A is incorporated by reference into this news release. The MD&A is available on the Company's issuer profiles on SEDAR+ at and on the SEC's EDGAR website at Net Revenue, Adjusted Gross Profit and Margin Net revenue, adjusted gross profit before FV adjustments, and adjusted gross margin before FV adjustments are Non-GAAP Measures and can be reconciled with revenue, gross profit and gross margin, the most directly comparable GAAP financial measures, respectively, as follows: ($ thousands) Three months ended Years ended March 31, 2025 December 31, 2024(2) March 31, 2024(2) March 31, 2025 March 31, 2024(3) Medical cannabis net revenue(1)Canadian medical cannabis net revenue 26,751 27,295 26,449 107,432 103,068 International medical cannabis net revenue 41,025 40,854 19,199 137,010 72,449 Total medical cannabis net revenue 67,776 68,149 45,648 244,442 175,517 Consumer cannabis net revenue(1)Consumer cannabis net revenue(1) 8,166 9,912 10,233 40,033 46,958 Wholesale bulk cannabis net revenue(1) 826 1,240 1,114 4,436 2,403 Total cannabis net revenue(1) 76,768 79,301 56,995 288,911 224,878— Plant propagation revenue 13,770 8,897 10,416 54,382 44,759 Total net revenue(1) 90,538 88,198 67,411 343,293 269,637 (1) Net revenue is a Non-GAAP Measure and is defined in the "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of this MD&A. Refer to the "Cost of Sales and Gross Margin" section of this MD&A for a reconciliation to IFRS equivalent. (2) Certain previously reported amounts have been adjusted to exclude the results related to discontinued operations. Adjusted EBITDA The following is the Company's adjusted EBITDA: ($ thousands) Three months ended Twelve months ended March 31, 2025 December 31, 2024(6) March 31, 2024(5) March 31, 2025 March 31, 2024(5) Net income (loss) from continuing operations (17,232) 28,110 (20,267) 15,763 (57,083) Income tax expense (recovery) 3,693 (377) (711) 4,619 (554) Other income (expense) (10,490) 4,821 18,719 (15,434) 12,536 Share-based compensation 3,786 1,657 3,029 12,930 12,717 Depreciation and amortization 6,322 6,030 6,296 25,470 32,066 Acquisition costs 624 819 2,970 3,435 5,326 Inventory and biological assets fair value and impairment adjustments 22,225 (28,311) (16,940) (17,905) (25,540) Business transformation related charges (1) 5,983 4,780 7,539 18,996 25,189 Out-of-period adjustments (2) — — (185) — 1,236 Non-recurring items (3) 1,767 1,864 1,869 1,835 7,859 Adjusted EBITDA (4) 16,678 19,393 2,319 49,709 13,752 (1) Business transformation related charges include costs related to closed facilities, certain IT project costs, costs associated with the repurposing of Sky and Sun, severance and retention costs in connection with the business transformation plan, and costs associated with the retention of certain medical aggregators. Some prior period amounts have been adjusted for changes in presentation. (2) Out-of-period adjustments reflect adjustments to net loss for the financial impact of transactions recorded in the current period that relate to prior periods. Some prior period amounts have been adjusted for changes in presentation. (3) Non-recurring items includes one-time excise tax refunds, non-core adjusted wholesale bulk margins, inventory count adjustments resulting from facility shutdowns and inter-site transfers, litigation and non-recurring project costs. (4) Adjusted EBITDA is a Non-GAAP Measure and is not a recognized, defined, or standardized measure under IFRS. Refer to "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of the MD&A. Prior period comparatives were adjusted to include the adjustments for markets under development, business transformation costs and non-recurring charges related to non-core bulk cannabis wholesale to be comparable to the current period presentation. (5) Certain previously reported amounts have been adjusted to exclude the results of discontinued operations. (6) In connection with the audit of the annual consolidated financial statements as at and for the year ended March 31, 2025, the Company noted that inventory and lease obligation were misstated, impacting the condensed consolidated interim statements filed during the 2025 fiscal year. Certain balances in the condensed consolidated interim financial statements as at and for the three months ended June 30, 2024, September 30, 2024 and December 31, 2024 were adjusted as a result and the amounts shown above reflect such adjustments. Refer to discussion under "Historical Quarterly Results" section of this MD&A for further detail. Adjusted SG&A Adjusted SG&A is a Non-GAAP Measure and can be reconciled with sales and marketing and general and administrative expenses, the most directly comparable GAAP financial measure, as follows:Three months ended Twelve months ended ($ thousands) March 31, 2025 December 31, 2024(3) March 31, 2024(2) March 31, 2025 March 31, 2024(2) General and administration 28,552 23,687 25,418 97,257 91,325 Sales and marketing 15,459 13,077 14,530 56,281 51,910 Business transformation costs (5,837) (5,128) (6,862) (20,326) (22,590) Out-of-period adjustments — — (642) — (1,236) Non-recurring costs (1,487) (373) (1,093) (2,144) (3,768) Adjusted SG&A (1) 36,687 31,263 31,351 131,068 115,641 (1) Adjusted SG&A is a Non-GAAP Measure and is not a recognized, defined, or standardized measure under IFRS. Refer to the "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of this MD&A. (2) Certain previously reported amounts have been adjusted to exclude the results of discontinued operations. (3) In connection with the audit of the annual consolidated financial statements as at and for the year ended March 31, 2025, the Company noted that inventory and lease obligation were misstated, impacting the condensed consolidated interim statements filed during the 2025 fiscal year. Certain balances in the condensed consolidated interim financial statements as at and for the three months ended June 30, 2024, September 30, 2024 and December 31, 2024 were adjusted as a result and the amounts shown above reflect such adjustments. Refer to discussion under "Historical Quarterly Results" section of this MD&A for further detail. Free Cash Flow The table below outlines free cash flow for the periods ended:Three months ended Years ended ($ thousands) March 31, 2025 December 31, 2024(3) March 31, 2025 March 31, 2025 March 31, 2024(3) Cash provided by (used in) operating activities from continuing operations before changes in non-cash working capital (2,928) 9,513 (10,074) 7,996 (47,625) Changes in non-cash working capital 6,947 20,107 (10,335) 10,210 (15,541) Net cash provided by (used in) operating activities from continuing operations 4,019 29,620 (20,409) 18,206 (63,166) Less: maintenance capital expenditures(1) (1,524) (2,256) (1,457) (8,290) (6,582) Free cash flow(2) 2,495 27,364 (21,866) 9,916 (69,748) (1) Maintenance capital expenditures are comprised of costs to sustain facilities, machinery and equipment in working order to support operations and excludes discretionary investments for revenue growth. (2) Free cash flow is a Non-GAAP Measure and is not a recognized, defined, or a standardized measure under IFRS. Refer to the "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" section of this MD&A. (3) Certain previously reported amounts have been adjusted for a reclassification of restricted cash to cash and cash equivalents as at March 31, 2024, June, 30, 2024, September 30, 2024 and December 31, 2024. Refer to discussion under "Historical Quarterly Results" section of the MD&A for further detail. Working Capital Working capital is a Non-GAAP Measure and can be reconciled with total current assets and total current liabilities, the most directly comparable GAAP financial measure, as follows:Three months ended ($ thousands) March 31, 2025 December 31, 2024 March 31, 2024 Total current assets 478,328 488,548 426,605 Total current liabilities (110,863) (149,807) (124,620) Working capital(1) 367,465 338,741 301,985 (1) Working capital for the three months ended December 31, 2024 has been adjusted. Refer to discussion under "Liquidity and Capital Resources" section of the MD&A. View original content to download multimedia: SOURCE Aurora Cannabis Inc. View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Canada's construction industry gets serious about investing in technology as pressure mounts to do more with less
Canada's construction industry gets serious about investing in technology as pressure mounts to do more with less

Yahoo

time2 hours ago

  • Yahoo

Canada's construction industry gets serious about investing in technology as pressure mounts to do more with less

Nine in 10 construction leaders say digital tools are needed to boost productivity to build more, faster, finds new KPMG in Canada report TORONTO, June 18, 2025 /CNW/ - In the face of growing pressure to build more, faster, nine in 10 Canadian construction leaders agree that the industry must move quickly to embrace new and advanced technologies, with most saying digital tools are already starting to boost their productivity, finds a new KPMG in Canada report on digital maturity in the construction industry. "It is good to see that the sector is investing in the technologies that are desperately needed to address persistently poor productivity levels," says Tom Rothfischer, Partner and National Industry Leader, Building, Construction and Real Estate, KPMG in Canada. "These investments are about to pay dividends and transform how we build in Canada. But the current economic and trade environment is squeezing bottom lines, putting at risk much-needed continued spending on tech – technology that is essential if we are to address the chronic housing supply shortage in this country and transform our economy through an ambitious era of nation-building mega-projects." Clients – those who commission and fund construction projects -- can play a key role in influencing the industry to modernize, the report says. Nearly eight in 10 (78 per cent) say procurement processes are changing to encourage innovation and digital adoption, and 43 per cent indicated that their clients play a "highly influential" role in their decision to adopt technologies. "It's encouraging to see signs that procurement is beginning to evolve, but we're not there yet," says Rodrigue Gilbert, President of the Canadian Construction Association. "Too often, the system prioritizes lowest price over long-term value, which prohibits investment in innovation. If we want a modern, productive construction sector, governments must reform procurement to foster collaboration, ensure fair risk-sharing, and create the confidence companies need to invest and grow." The level of tech investment will need to ramp up given that the industry's labour crunch is expected to worsen as the workforce ages and retirements increase in the next decade, the report points out. Nearly three-quarters (73 per cent) of construction leaders expect that it will become "increasingly difficult" to meet demand over the next five-to-10 years, particularly as retirements outpace recruitment. "The pressure is intensifying on the construction industry to do far more with less," says Jordan Thomson, Director, Global Infrastructure Advisory, KPMG in Canada. "The industry is well aware of their labour conundrum, with eight in 10 companies still experiencing a shortage in skilled labour that's affecting their ability to take on new work and complete current jobs. While it's improved slightly from two years ago, it's still incredibly high. "The industry is also counting on the removal of interprovincial trade barriers," he adds. "The challenges of working under 14 different sets of provincial rules and regulations is a further and unneeded drag on productivity that needs to be addressed if we expect the industry to be able to handle the growing volume of projects in the pipeline." The report finds that the industry is focused on deploying a wide range of technologies to improve productivity and expedite project completion, with 81 per cent of construction companies saying their recent investments in technology are already making a difference. Some of these technologies include advancements in modular or prefabrication construction that streamline processes, reduce waste, and accelerate timelines by constructing buildings in a controlled factory environment and then transporting them to the construction site for assembly; robotics and automation, such as robotic bricklaying that improves productivity and safety, or drones for site surveys; and, building information modelling (BIM), which improves planning and collaboration among stakeholders by providing a comprehensive digital view of the project from the architectural design to the materials, systems and infrastructure that will be needed. Investing in technologies to create a demand-driven supply chain that aligns supply with actual demand was ranked the top priority by more than half (56 per cent) of respondents surveyed, the report finds. "The industry has always faced supply chain challenges, whether it's the cost or availability of materials," says Mr. Thomson. "But that's recently been exacerbated by, among other things, U.S. tariffs, ongoing ripple effects from the pandemic, and other global macroeconomic events, prompting many companies to invest in supply chain innovation that uses digital tools, data analytics and automation that drive real-time visibility into projects and material requirements." The report shows that industry players are prioritizing a number of new technologies in parallel, spanning from 56 per cent exploring demand-driven supply chain innovation to 40 per cent exploring robotics, drones, exoskeletons. More than half (53 per cent) are prioritizing prefabrication as well as artificial intelligence (AI) and AI-driven software. Engineering firms and suppliers are focused on deploying intelligent automation, institutional owners are investing in AI, and contractors are prioritizing cybersecurity technologies. "We're seeing much more interest in tech adoption compared to where we were even two years ago. However, the sector still has a long way to go to move the needle on productivity," says Mr. Thomson. "Making a commitment to invest in technology is the first step. Delivering returns requires careful integration and only works if you also invest in up-skilling your people to use it effectively." Key Survey Findings: 87 per cent of 265 Canadian construction leaders agree the industry will need to implement new and advanced technologies to meet the demand for housing 90 per cent agree that better tools, such as AI, analytics, BIM and digital twins, can boost efficiency and labour effectiveness, up from 86 per cent in 2023 78 per cent say procurement processes are changing to encourage innovation and digital adoption 43 per cent say their clients are "highly influential" in their decision to adopt technology to meet project or contractual requirements 73 per cent expect it will become "increasingly difficult" to meet demand over the next five-to-10 years, particularly as retirements outpace recruitment 78 per cent are currently experiencing a shortage of skilled workers, compared to 90 per cent in 2023 70 per cent say the labour crunch is impacting their ability to bid on new projects and/or meet project deadlines, compared to 86 per cent in 2023 84 per cent want to see interprovincial trade barriers eliminated as quickly as possible 81 per cent say labour productivity and efficiency has improved as a result of their company's recent investments in technology 56 per cent are prioritizing technologies underpinning a demand-driven supply chain 53 per cent are making prefabrication and modularization a top or high priority in their business and another 27 per cent have it as mid-level priority 53 per cent are also prioritizing AI and AI-driven software "The construction sector is the foundation of Canada's nation-building ambitions. From housing to trade-enabling infrastructure to clean energy, nothing gets built without us," said Mr. Gilbert. "It's time for coordinated action. The government must modernize procurement, cut red tape, and provide the clear, consistent policy direction our sector needs to deliver. The time to act—together—is now." Read the full report here. About the SurveyIn its third biennial survey, KPMG in Canada surveyed 265 construction companies across Canada from March 18 through April 4, 2025, in collaboration with the Canadian Construction Association to measure the sector's digital maturity. The survey was conducted among KPMG clients and Sago's construction industry business panel respondents on the polling agency's online Methodify platform. The survey included general contractors (63 per cent), engineering firms (15 per cent), subcontractors (12 per cent), suppliers (8 per cent), and institutional owners (3 per cent). About KPMG in CanadaKPMG LLP, a limited liability partnership, is a full-service Audit, Tax and Advisory firm owned and operated by Canadians. For over 150 years, our professionals have provided consulting, accounting, auditing, and tax services to Canadians, inspiring confidence, empowering change, and driving innovation. Guided by our core values of Integrity, Excellence, Courage, Together, For Better, KPMG employs more than 10,000 people in over 40 locations across Canada, serving private- and public-sector clients. KPMG is consistently ranked one of Canada's top employers and one of the best places to work in the country. The firm is established under the laws of Ontario and is a member of KPMG's global organization of independent member firms affiliated with KPMG International, a private English company limited by guarantee. Each KPMG firm is a legally distinct and separate entity and describes itself as such. For more information, see About the Canadian Construction AssociationCCA represents more than 18,000 member firms drawn from 57 local and provincial integrated partner associations across Canada. CCA gives voice to the public policy, legal and standards development goals of contractors, suppliers and allied business professionals working in, or with, Canada's institutional, commercial, industrial, civil and multi-residential construction industry. The construction sector is one of Canada's largest employers and a major contributor to the country's economic success. The industry, 99.6 per cent of which is made up of small and medium enterprises, employs more than 1.6 million Canadians and contributes 7.5 per cent of Canada's Gross Domestic Product. For media inquiries: Caroline Van HasseltNational Communications and Media RelationsKPMG in Canada(416) 777-3288cvanhasselt@ Anthony ValentiManager, Media Relations Canadian Construction Association(613) 608-2716 avalenti@ SOURCE KPMG LLP View original content to download multimedia: Sign in to access your portfolio

Column: Charles Ponzi's fascinating twist on the American Dream — as played by Sebastian Maniscalco
Column: Charles Ponzi's fascinating twist on the American Dream — as played by Sebastian Maniscalco

Chicago Tribune

time2 hours ago

  • Chicago Tribune

Column: Charles Ponzi's fascinating twist on the American Dream — as played by Sebastian Maniscalco

More than 100 years ago, the name Charles Ponzi was splashed on newspaper front pages across the land and poured from radio broadcasts, putting the phrase 'Ponzi Scheme' firmly into the arsenal of generations of would-be con artists. Sebastian Maniscalco, an Arlington Heights native who worked at a McDonald's long before becoming a successful actor and comedian, had very little knowledge of Ponzi when he got a call from a man named Will Malnati. 'I had once almost, almost, been the victim of a Ponzi scheme in the early 2000s,' Maniscalco told me. 'So at least I knew the name.' Malnati, a native of Northbrook and Northfield and a proud part of a family pizza empire, founded At Will Media in 2016, a Brooklyn-based, independently-owned podcast studio. It has produced many fine programs, including, in partnership with the Tribune, 'Unsealed: The Tylenol Murders' in 2022, and the haunting 'The Last Days of Cabrini-Green' last year. These two men have created an enlightening and entertaining eight-episode podcast series. 'Easy Money: The Charles Ponzi Story' is an Apple Original Podcast, produced by At Will Media, with Maniscalco as Ponzi. You can hear its first two episodes now, with future episodes arriving weekly through July 28. And here's how it came to be. 'A friend had sent me a YouTube link about Charles Ponzi, a pretty crude piece taped in a basement,' Malnati said. 'I didn't know much about Ponzi. I had heard the name, of course, but knew almost nothing about the man. So I started digging around and couldn't find a great deal. I wanted more, and so I started thinking of how this story could be told.' He was further grabbed by what he found to be marked similarities between Ponzi and Maniscalco. 'I only knew Sebastian as a fan, but I found his resemblance to Ponzi so striking that I gave him a call to see if he was interested in a project.' Maniscalco was a very busy man. Not only was he regularly on tour, often with Chicago's Pat McGann as his opening act, he has released six comedy specials, has had supporting roles in such films as 'The Green Mile' and 'The Irishman,' and wrote and starred, with Robert DeNiro, in 'About My Father.' Not incidentally, was already part of the podcast world, with 'The Pete and Sebastian Show,' which he described to me as, 'Just me and my buddy Pete (Correale, a stand-up comic and writer) sitting around talking.' Amid all of that, Maniscalco found time to listen to Malnati. 'I didn't know much about storytelling podcasts,' he said. To enlighten him, Malnati sent him links to 'Wild Things: Siegfried & Roy,' the Apple Original podcast produced by At Will Media in 2021. Maniscalco listened, often during the 20 minutes he spends each morning in a steam room. His reaction was 'Wow, this is fantastic.' And so did these two children of the Chicago suburbs team up, along with many others, to create Apple's first original scripted podcast. Fascinating in its details, 'Easy Money: The Charles Ponzi Story,' is polished in its production, each episode in the neighborhood of 40 minutes. There are many other characters, good ones and nasty ones. Yes, it focuses on a colorful, wide-reaching criminal but, thanks to some recently discovered letters, it's a love story too. The relationship between Ponzi and his wife Rose (performed by Candice Shedd-Thompson) is memorably touching. So, when I say Ponzi, what pops into your mind? Likely the face of Bernie Madoff, who orchestrated the largest Ponzi scheme in history which usually fails to credit, even mention, the creator of the scheme which is defined as 'a form of fraud that lures investors and pays profits to earlier investors with funds from more recent investors.' Though there were variations of this boondoggle before Ponzi, he was its most colorful and talented practitioner (for a surprisingly short time), a 5-foot, 2-inch tall Italian immigrant of ambitions that eventually turned avaricious. Hosted with considerable charm by Maya Lau, a former Los Angeles Times reporter and podcaster, deeply researched and stylishly written by Matt Hickey and Kevin Hynes, it is directed by Katie Finneran, also from Chicago. This was all new to Maniscalco, who says, 'In my comedy, there's a lot of visualization in the way I tell stories. I can see things in my head. In movies, I'm on a set. I'm in the Copacabana in the 'Irishman,' there's Don Rickles over there on the stage. I don't have to visualize. Everything's right there in front of me. For this I'm alone in a sound booth. I have to use my imagination to create in my mind the Ponzi world, his office, the people around him. And I'm not moving and I like to move.' He found it all 'great learning experience' but also 'the hardest thing I've done in my career. … It's what I think might just be a new category, a new kind of podcast.' I told him I found his performance so energetic that I started feeling a grudging respect for Ponzi. 'I get that. This guy was sincere, misguided rather than evil,' Maniscalco told me. 'I think he felt a lot of pressure, especially from his mother, to grab the American Dream. He didn't come here to rip off the whole country and I know he had some regrets but it was amazing, the way he was able to seduce people. But still, a part of me feels sorry for the guy.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store